MTBDRplus and MTBDRsl Assays: Absence of wild-type probe hybridization and implications for detection of drug-resistant tuberculosis

Journal of Clinical Microbiology

Volumn 54, Issue 4, 2016, Pages 912-918

  Seifert, Marva ^a   Georghiou, Sophia B ^a   Catanzaro, Donald ^b   Rodrigues, Camilla ^c   Crudu, Valeriu ^d   Victor, Thomas C ^e   Garfein, Richard S ^a   Catanzaro, Antonino ^a   Rodwell, Timothy C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARKANSAS   (United States)

^c P D HINDUJA NATIONAL HOSPITAL   (India)

^d Microbiology and Morphology Laboratory   (Moldova)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANT TUBERCULOSIS; HUMAN; HYBRIDIZATION; MOLECULAR PROBE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PYROSEQUENCING; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SPUTUM ANALYSIS; WILD TYPE; COMPARATIVE STUDY; DNA SEQUENCE; DRUG EFFECTS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MOLECULAR DIAGNOSIS; NUCLEIC ACID HYBRIDIZATION; PROCEDURES; PROSPECTIVE STUDY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID HYBRIDIZATION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84962494172     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02505-15     Document Type: Article

References (34)

1. World Health Organization. 2014. Global tuberculosis report 2014. World Health Organization, Geneva, Switzerland.
2. World Health Organization. 2014. Drug-resistant TB surveillance and response. World Health Organization, Geneva, Switzerland.
3. World Health Organization. 2015. Global tuberculosis report 2015. World Health Organization, Geneva, Switzerland.
4. Hoek KG, Van Rie A, van Helden PD, Warren RM, Victor TC. 2011. Detecting drug-resistant tuberculosis: The importance of rapid testing. Mol Diagn Ther 15:189-194. http://dx.doi.org/10.1007/BF03256410.
5. Kalokhe AS, Shafiq M, Lee JC, Ray SM, Wang YF, Metchock B, Anderson AM, Nguyen ML. 2013. Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing. Am J Med Sci 345:143-148. http://dx.doi.org/10.1097/MAJ.0b013e31825d32c6.
6. Boehme CC, Saacks S, O'Brien RJ. 2013. The changing landscape of diagnostic services for tuberculosis. Semin Respir Crit Care Med 34:17-31. http://dx.doi.org/10.1055/s-0032-1333468.
7. Bwanga F, Hoffner S, Haile M, Joloba ML. 2009. Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis. BMC Infect Dis 9:67. http://dx.doi.org/10.1186/1471-2334-9-67.
8. Drobniewski F, Nikolayevskyy V, Maxeiner H, Balabanova Y, Casali N, Kontsevaya I, Ignatyeva O. 2013. Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation. BMC Med 11:190. http://dx.doi.org/10.1186/1741-7015-11-190.
9. Ahmad S, Mokaddas E. 2009. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 103:1777-1790. http://dx.doi.org/10.1016/j.rmed.2009.07.010.
10. Alcaide F, Coll P. 2011. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance. Enferm Infecc Microbiol Clin 29(Suppl):S34-S40.
11. Naidoo P, du Toit E, Dunbar R, Lombard C, Caldwell J, Detjen A, Squire SB, Enarson DA, Beyers N. 2014. A comparison of multidrugresistant tuberculosis treatment commencement times in MDRTBplus line probe assay and Xpert MTB/RIF-based algorithms in a routine operational setting in Cape Town. PLoS One 9(7):e103328. http://dx.doi.org/10.1371/journal.pone.0103328.
12. O'Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, Zumla A. 2011. New and improved diagnostics for detection of drugresistant pulmonary tuberculosis. Curr Opin Pulm Med 17:134-141. http://dx.doi.org/10.1097/MCP.0b013e3283452346.
13. Pai M, Schito M. 2015. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis 211:S21-S28. http://dx.doi.org/10.1093/infdis/jiu803.
14. Feng Y, Liu S, Wang Q, Wang L, Tang S, Wang J, Lu W. 2013. Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: A metaanalysis. PLoS One 8(2):e55292. http://dx.doi.org/10.1371/journal.pone.0055292.
15. Theron G, Peter J, Richardson M, Barnard M, Donegan S, Warren R, Steingart KR, Dheda K. 2014. The diagnostic accuracy of the GenoType MTBDRsl assay for the detection of resistance to second-line antituberculosis drugs. Cochrane Database Syst Rev 10:CD010705.
16. Lacoma A, Garcia-Sierra N, Prat C, Maldonado J, Ruiz-Manzano J, Haba L, Gavin P, Samper S, Ausina V, Dominguez J. 2012. GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 50:30-36. http://dx.doi.org/10.1128/JCM.05274-11.
17. Kaswa MK, Aloni M, Nkuku L, Bakoko B, Lebeke R, Nzita A, Muyembe JJ, de Jong BC, de Rijk P, Verhaegen J, Boelaert M, Ieven M, Van Deun A. 2014. Pseudo-outbreak of pre-extensively drug-resistant (Pre-XDR) tuberculosis in Kinshasa: collateral damage caused by false detection of fluoroquinolone resistance by GenoType MTBDRsl. J Clin Microbiol 52: 2876-2880. http://dx.doi.org/10.1128/JCM.00398-14.
18. Aubry A, Sougakoff W, Bodzongo P, Delcroix G, Armand S, Millot G, Jarlier V, Courcol R, Lemaitre N. 2014. First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA. PLoS One 9(4):e95083. http://dx.doi.org/10.1371/journal.pone.0095083.
19. Laurenzo D, Mousa SA. 2011. Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing. Acta Trop 119:5-10. http://dx.doi.org/10.1016/j.actatropica.2011.04.008.
20. Hillery N, Groessl EJ, Trollip A, Catanzaro D, Jackson L, Rodwell TC, Garfein RS, Lin SY, Eisenach K, Ganiats TG, Park D, Valafar F, Rodrigues C, Crudu V, Victor TC, Catanzaro A. 2014. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis. Trials 15:434. http://dx.doi.org/10.1186/1745-6215-15-434.
21. Catanzaro A, Rodwell TC, Catanzaro DG, Garfein RS, Jackson RL, Seifert M, Georghiou SB, Trollip A, Groessl E, Hillery N, Crudu V, Victor TC, Rodrigues C, Lin GS, Valafar F, Desmond E, Eisenach K. 2015. Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis. PLoS One 10(8):e0136861. http://dx.doi.org/10.1371/journal.pone.0136861.
22. Hain Lifescience GmbH. 2012. GenoType MTBDRplus version 2.0: instruction manual. Hain Lifescience GmbH, Nehren, Germany.
23. Hain Lifescience GmbH. 2009. GenoType MTBDRsl version 1.0: instruction manual. Hain Lifescience GmbH, Nehren, Germany.
24. Hillemann D, Rusch-Gerdes S, Richter E. 2007. Evaluation of the Geno-TypeMTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 45:2635-2640. http://dx.doi.org/10.1128/JCM.00521-07.
25. Lin SY, Desmond EP. 2014. Molecular diagnosis of tuberculosis and drug resistance. Clin Lab Med 34:297-314. http://dx.doi.org/10.1016/j.cll.2014.02.005.
26. Lin SY, Rodwell TC, Victor TC, Rider EC, Pham L, Catanzaro A, Desmond EP. 2014. Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. J Clin Microbiol 52:475-482. http://dx.doi.org/10.1128/JCM.01821-13.
27. Newcombe RG. 1998. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med 17:2635-2650. http://dx.doi.org/10.1002/(SICI)1097-0258(19981130)17:22-2635::AID-SIM954-3.0.CO;2-C.
28. Tracevska T, Jansone I, Broka L, Marga O, Baumanis V. 2002. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol 40:3789-3792. http://dx.doi.org/10.1128/JCM.40.10.3789-3792.2002.
29. Singhal R, Myneedu VP, Arora J, Singh N, Sah GC, Sarin R. 2014. Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North-Eastern States of India using GenoType MTBDRplus assay. Indian J Med Res 140:501-506.
30. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. 2006. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low-and high-level resistance. J Clin Microbiol 44:3659-3664. http://dx.doi.org/10.1128/JCM.01054-06.
31. Huyen MN, Tiemersma EW, Lan NT, Cobelens FG, Dung NH, Sy DN, Buu TN, Kremer K, Hang PT, Caws M, O'Brien R, van Soolingen D. 2010. Validation of the GenoTypeMTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis 10:149. http://dx.doi.org/10.1186/1471-2334-10-149.
32. Buu TN, Huyen MN, van Soolingen D, Lan NT, Quy HT, Tiemersma EW, Borgdorff MW, Cobelens FG. 2010. The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam. Clin Infect Dis 51:879-886. http://dx.doi.org/10.1086/656410.
33. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. 2010. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol 48:1683-1689. http://dx.doi.org/10.1128/JCM.01947-09.
34. Huang WL, Chi TL, Wu MH, Jou R. 2011. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 49: 2502-2508. http://dx.doi.org/10.1128/JCM.00197-11.